Literature DB >> 6768535

Evidence for hepatitis B and other virus infection in HBsAg-negative chronic active hepatitis.

E Villa, P Jenkins, B Portmann, A L Eddleston, R Williams.   

Abstract

Antibody to the hepatitis B core antigen (anti-HBc) was detected in sera from 6 (19%) of 32 patients with HBsAg-negative chronic active hepatitis. In three cases with the highest anti-HBc titers, core antigen was detected in liver cell nuclei and in one case HBsAg was also present in hepatocytes, suggesting continuing hepatitis B virus infection. During follow-up, anti-HBc titers fell slowly in those with no viral antigens in liver tissue, and in two cases with virus in the liver at presentation, viral antigens were no longer demonstrable four and eight years later. In one case, clearance of virus was preceded by the appearance of HBsAg in liver and serum, suggesting reactivation of viral replication. In three of the anti-HBc-negative cases a nuclear antigen unrelated to the hepatitis B virus was detected by immunofluorescence, and it is possible that liver disease in these patients may be related to persistent non-A, non-B virus infection.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6768535     DOI: 10.1007/bf01308058

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  Hepatits A virus infection in fulminant hepatitis and chronic active hepatitis.

Authors:  J Rakela; A G Redeker; V M Edwards; R Decker; L R Overby; J W Mosley
Journal:  Gastroenterology       Date:  1978-05       Impact factor: 22.682

2.  Detection of hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain.

Authors:  W D Reed; R B Stern; A L Eddleston; R Williams; A J Zuckerman; A Bowes; P M Earl
Journal:  Lancet       Date:  1973-09-29       Impact factor: 79.321

3.  Australia antigen and smooth-muscle antibody in acute and chronic hepatitis.

Authors:  R Wright
Journal:  Lancet       Date:  1970-03-07       Impact factor: 79.321

4.  Post-transfusion chronic liver disease.

Authors:  R L Koretz; S C Suffin; G L Gitnick
Journal:  Gastroenterology       Date:  1976-11       Impact factor: 22.682

5.  Differential distribution of hepatitis B surface antigen and hepatitis B core antigen in the liver of hepatitis B patients.

Authors:  M B Ray; V J Desmet; A F Bradburne; J Desmyter; J Fevery; J De Groote
Journal:  Gastroenterology       Date:  1976-09       Impact factor: 22.682

6.  Antibody to hepatitis B core antigen in chronic active hepatitis.

Authors:  P Bories; P Coursaget; A Goudeau; C Degott; P Maupas; J P Benhamou
Journal:  Br Med J       Date:  1978-02-18

7.  Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen.

Authors:  J H Hoofnagle; L B Seeff; Z B Bales; H J Zimmerman
Journal:  N Engl J Med       Date:  1978-06-22       Impact factor: 91.245

8.  Transmission of non-A non-B hepatitis to chimpanzees by factor-IX concentrates after fatal complications in patients with chronic liver disease.

Authors:  R J Wyke; K N Tsiquaye; A Thornton; Y White; B Portmann; P K Das; A J Zuckerman; R Williams
Journal:  Lancet       Date:  1979-03-10       Impact factor: 79.321

9.  Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis. Role of gamma-globulin prophylaxis in its prevention.

Authors:  R G Knodell; M E Conrad; K G Ishak
Journal:  Gastroenterology       Date:  1977-05       Impact factor: 22.682

10.  Reactivation of hepatitis b after transplantation operations.

Authors:  J Nagington
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

View more
  1 in total

1.  Incidence and significance of hepatitis B and A virus serologic markers in Greek cirrhotic patients.

Authors:  G Theodoropoulos; G Hadzis
Journal:  Gastroenterol Jpn       Date:  1985-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.